Logo for Curasight

Curasight Investor Relations Material

Latest events

Logo for Curasight

Investor Update

Curasight
Logo for Curasight

Investor Update

2 May, 2025
Logo for Curasight

Q1 2025

25 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Curasight

Access all reports
Curasight is a clinical stage biopharmaceutical company dedicated to developing uPAR Theranostics for the early detection, diagnosis and treatment of cancer. The company's mission is to make a global impact by harnessing imaging technology that improves diagnosis and correlates to improved long-term patient outcome.